Cecile Redon

Chief Executive Officer

Professional Overview
Cecile Redon is an accomplished executive with extensive experience in the medical technology industry. As the Chief Executive Officer of BrightHeart and a Partner at Sofinnova Partners, she leverages her deep expertise in clinical, regulatory, and market access to drive innovation and growth for her portfolio companies.

Experience Summary

Current Roles
Chief Executive Officer, BrightHeart (2022-11-01 to Present)
As the CEO of BrightHeart, Cecile is responsible for leading the company's strategic vision, overseeing product development, and driving commercial expansion. Under her guidance, BrightHeart has introduced groundbreaking medical technologies that have significantly improved patient outcomes.

Partner - MD Start, Sofinnova Partners (2023-02-01 to Present)
In her role as a Partner at Sofinnova Partners, Cecile leverages her extensive industry knowledge and network to identify, invest in, and mentor early-stage medical technology startups. Her strategic insights and hands-on approach have been instrumental in the growth and success of multiple portfolio companies.

Board Member, Endoron Medical (2021-09-01 to Present)
Cecile serves on the board of Endoron Medical, providing strategic guidance and oversight to help the company navigate the regulatory landscape and accelerate the commercialization of its innovative medical devices.

Career Progression
Cecile's career in the medical technology industry spans over a decade, during which she has held various leadership positions. Prior to her current roles, she served as the President (previously CEO) of HEPTA Medical, the COO of Gradient Denervation Technologies, and held clinical, regulatory, and market access roles at SafeHeal, DAMAE Medical, and Mauna Kea Technologies.

Throughout her career, Cecile has demonstrated a track record of driving innovation, optimizing operational efficiency, and navigating complex regulatory and market environments. Her contributions have resulted in the successful commercialization of multiple medical devices and the growth of the companies she has been associated with.

Academic Background
Cecile holds a Master's degree in Biomedical Engineering from the University of Paris, where she specialized in medical device development and regulatory affairs.

Areas of Expertise

• Medical device development and commercialization

• Clinical, regulatory, and market access strategy

• Venture capital and investment in the medtech sector

• Operational optimization and organizational leadership

• Strategic planning and business development

Professional Impact
Under Cecile's leadership, BrightHeart has emerged as a prominent player in the medical technology industry, introducing innovative solutions that have improved patient outcomes and healthcare delivery. Additionally, her work at Sofinnova Partners has supported the growth and success of multiple early-stage medical technology startups, driving meaningful advancements in the field.

Conclusion
Cecile Redon's extensive experience, strategic vision, and proven track record of success make her a valuable asset in the medical technology industry. As she continues to lead BrightHeart and guide Sofinnova Partners' portfolio companies, she is poised to drive further innovation and positively impact the lives of patients worldwide.